{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib4oiryjdpvy34a5q7wa6lw6qnuaty6dfejtn2n3on3ztmlbbboyy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjwxoi6eiee2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicoleskmsnajzngq6ppmnwlvps24sftyr6sie4xjmxevrqnpsnvwi"
    },
    "mimeType": "image/jpeg",
    "size": 945975
  },
  "path": "/news/2026-04-deep-pathomics-platform-response-immunotherapy.html",
  "publishedAt": "2026-04-20T12:00:08.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC), according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17–22.",
  "title": "A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients"
}